[
  {
    "title": "InternationalAmericasAsia PacificEuropeMiddle East & Africa",
    "link": "https://www.novartis.com/news#international",
    "timestamp": "unknown"
  },
  {
    "title": "InternationalAmericasAsia PacificEuropeMiddle East & Africa",
    "link": "https://www.novartis.com/news#international",
    "timestamp": "unknown"
  },
  {
    "title": "International",
    "link": "https://www.novartis.com/news#international",
    "timestamp": "unknown"
  },
  {
    "title": "Americas",
    "link": "https://www.novartis.com/news#americas",
    "timestamp": "unknown"
  },
  {
    "title": "Asia Pacific",
    "link": "https://www.novartis.com/news#asia-pacific",
    "timestamp": "unknown"
  },
  {
    "title": "Europe",
    "link": "https://www.novartis.com/news#europe",
    "timestamp": "unknown"
  },
  {
    "title": "Middle East & Africa",
    "link": "https://www.novartis.com/news#middle-east-africa",
    "timestamp": "unknown"
  },
  {
    "title": "Global |EnglishNovartis Foundation |English",
    "link": "https://www.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Argentina |Espa\u00f1olBrazil |Portugu\u00easCanada |EnglishCanada |Fran\u00e7aisCentral America |Espa\u00f1olColombia |Espa\u00f1olMexico |Espa\u00f1olUnited States |English",
    "link": "https://www.novartis.com/ar-es/",
    "timestamp": "unknown"
  },
  {
    "title": "Australia |EnglishBangladesh |EnglishHong Kong S.A.R. |\u7e41\u9ad4\u4e2d\u6587India |EnglishIndonesia |EnglishJapan |\u65e5\u672c\u8a9eKorea |\ud55c\uad6d\uc5b4Mainland China |\u4e2d\u6587Malaysia |EnglishPaki",
    "link": "https://www.novartis.com/au-en/",
    "timestamp": "unknown"
  },
  {
    "title": "Egypt |EnglishIsrael |\u05e2\u05d1\u05e8\u05d9\u05eaSaudi Arabia |\u0627\u0644\u0639\u0631\u0628\u064a\u0629South Africa |English",
    "link": "https://www.novartis.com/eg-en/",
    "timestamp": "unknown"
  },
  {
    "title": "internationalInternationalAmericasAsia PacificEuropeMiddle East & Africa",
    "link": "https://www.novartis.com/news#international",
    "timestamp": "unknown"
  },
  {
    "title": "internationalInternationalAmericasAsia PacificEuropeMiddle East & Africa",
    "link": "https://www.novartis.com/news#international",
    "timestamp": "unknown"
  },
  {
    "title": "internationalInternationalAmericasAsia PacificEuropeMiddle East & Africa",
    "link": "https://www.novartis.com/news#international",
    "timestamp": "unknown"
  },
  {
    "title": "InternationalAmericasAsia PacificEuropeMiddle East & Africa",
    "link": "https://www.novartis.com/news#international",
    "timestamp": "unknown"
  },
  {
    "title": "MenuAboutBoard of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette Hel",
    "link": "https://www.novartis.com/about",
    "timestamp": "unknown"
  },
  {
    "title": "MenuAboutBoard of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette Hel",
    "link": "https://www.novartis.com/about",
    "timestamp": "unknown"
  },
  {
    "title": "AboutBoard of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerD",
    "link": "https://www.novartis.com/about",
    "timestamp": "unknown"
  },
  {
    "title": "AboutBoard of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerD",
    "link": "https://www.novartis.com/about",
    "timestamp": "unknown"
  },
  {
    "title": "AboutBoard of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerD",
    "link": "https://www.novartis.com/about",
    "timestamp": "unknown"
  },
  {
    "title": "AboutBoard of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerD",
    "link": "https://www.novartis.com/about",
    "timestamp": "unknown"
  },
  {
    "title": "AboutBoard of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerD",
    "link": "https://www.novartis.com/about",
    "timestamp": "unknown"
  },
  {
    "title": "Board of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel",
    "link": "https://www.novartis.com/about/board-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Board of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel",
    "link": "https://www.novartis.com/about/board-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Board of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel",
    "link": "https://www.novartis.com/about/board-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Board of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel",
    "link": "https://www.novartis.com/about/board-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Board of DirectorsGiovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel",
    "link": "https://www.novartis.com/about/board-directors",
    "timestamp": "unknown"
  },
  {
    "title": "Giovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel HochstrasserFrans",
    "link": "https://www.novartis.com/about/board-directors/giovanni-caforio",
    "timestamp": "unknown"
  },
  {
    "title": "Giovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel HochstrasserFrans",
    "link": "https://www.novartis.com/about/board-directors/giovanni-caforio",
    "timestamp": "unknown"
  },
  {
    "title": "Giovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel HochstrasserFrans",
    "link": "https://www.novartis.com/about/board-directors/giovanni-caforio",
    "timestamp": "unknown"
  },
  {
    "title": "Giovanni CaforioSimon MoroneyNancy C. AndrewsTon BuechnerPatrice BulaElizabeth (Liz) DohertyAna de Pro GonzaloBridgette HellerDaniel HochstrasserFrans",
    "link": "https://www.novartis.com/about/board-directors/giovanni-caforio",
    "timestamp": "unknown"
  },
  {
    "title": "Giovanni Caforio",
    "link": "https://www.novartis.com/about/board-directors/giovanni-caforio",
    "timestamp": "unknown"
  },
  {
    "title": "Simon Moroney",
    "link": "https://www.novartis.com/about/board-directors/simon-moroney",
    "timestamp": "unknown"
  },
  {
    "title": "Nancy C. Andrews",
    "link": "https://www.novartis.com/about/board-directors/nancy-c-andrews",
    "timestamp": "unknown"
  },
  {
    "title": "Ton Buechner",
    "link": "https://www.novartis.com/about/board-directors/ton-buechner",
    "timestamp": "unknown"
  },
  {
    "title": "Patrice Bula",
    "link": "https://www.novartis.com/about/board-directors/patrice-bula",
    "timestamp": "unknown"
  },
  {
    "title": "Elizabeth (Liz) Doherty",
    "link": "https://www.novartis.com/about/board-directors/elizabeth-liz-doherty",
    "timestamp": "unknown"
  },
  {
    "title": "Ana de Pro Gonzalo",
    "link": "https://www.novartis.com/about/board-directors/ana-de-pro-gonzalo",
    "timestamp": "unknown"
  },
  {
    "title": "Bridgette Heller",
    "link": "https://www.novartis.com/about/board-directors/bridgette-heller",
    "timestamp": "unknown"
  },
  {
    "title": "Daniel Hochstrasser",
    "link": "https://www.novartis.com/about/board-directors/daniel-hochstrasser",
    "timestamp": "unknown"
  },
  {
    "title": "Frans van Houten",
    "link": "https://www.novartis.com/about/board-directors/frans-van-houten",
    "timestamp": "unknown"
  },
  {
    "title": "Elizabeth McNally",
    "link": "https://www.novartis.com/about/board-directors/elizabeth-mcnally",
    "timestamp": "unknown"
  },
  {
    "title": "John D. Young",
    "link": "https://www.novartis.com/about/board-directors/john-d-young",
    "timestamp": "unknown"
  },
  {
    "title": "Charlotte Pamer-Wieser",
    "link": "https://www.novartis.com/about/board-directors/charlotte-pamer-wieser",
    "timestamp": "unknown"
  },
  {
    "title": "Executive CommitteeVasant (Vas) NarasimhanShreeram AradhyeVictor BultoAharon (Ronny) GalKaren L. HalePatrick HorberHarry KirschRob KowalskiSteffen Lan",
    "link": "https://www.novartis.com/about/executive-committee",
    "timestamp": "unknown"
  },
  {
    "title": "Vasant (Vas) NarasimhanShreeram AradhyeVictor BultoAharon (Ronny) GalKaren L. HalePatrick HorberHarry KirschRob KowalskiSteffen LangFiona MarshallLutz",
    "link": "https://www.novartis.com/about/executive-committee/vasant-narasimhan",
    "timestamp": "unknown"
  },
  {
    "title": "Vasant (Vas) NarasimhanShreeram AradhyeVictor BultoAharon (Ronny) GalKaren L. HalePatrick HorberHarry KirschRob KowalskiSteffen LangFiona MarshallLutz",
    "link": "https://www.novartis.com/about/executive-committee/vasant-narasimhan",
    "timestamp": "unknown"
  },
  {
    "title": "Vasant (Vas) NarasimhanShreeram AradhyeVictor BultoAharon (Ronny) GalKaren L. HalePatrick HorberHarry KirschRob KowalskiSteffen LangFiona MarshallLutz",
    "link": "https://www.novartis.com/about/executive-committee/vasant-narasimhan",
    "timestamp": "unknown"
  },
  {
    "title": "Vasant (Vas) NarasimhanShreeram AradhyeVictor BultoAharon (Ronny) GalKaren L. HalePatrick HorberHarry KirschRob KowalskiSteffen LangFiona MarshallLutz",
    "link": "https://www.novartis.com/about/executive-committee/vasant-narasimhan",
    "timestamp": "unknown"
  },
  {
    "title": "Vasant (Vas) Narasimhan",
    "link": "https://www.novartis.com/about/executive-committee/vasant-narasimhan",
    "timestamp": "unknown"
  },
  {
    "title": "Shreeram Aradhye",
    "link": "https://www.novartis.com/about/executive-committee/shreeram-aradhye",
    "timestamp": "unknown"
  },
  {
    "title": "Victor Bulto",
    "link": "https://www.novartis.com/about/executive-committee/victor-bulto",
    "timestamp": "unknown"
  },
  {
    "title": "Aharon (Ronny) Gal",
    "link": "https://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd",
    "timestamp": "unknown"
  },
  {
    "title": "Karen L. Hale",
    "link": "https://www.novartis.com/about/executive-committee/karen-hale",
    "timestamp": "unknown"
  },
  {
    "title": "Patrick Horber",
    "link": "https://www.novartis.com/about/executive-committee/patrick-horber-md",
    "timestamp": "unknown"
  },
  {
    "title": "Harry Kirsch",
    "link": "https://www.novartis.com/about/executive-committee/harry-kirsch",
    "timestamp": "unknown"
  },
  {
    "title": "Rob Kowalski",
    "link": "https://www.novartis.com/about/executive-committee/rob-kowalski",
    "timestamp": "unknown"
  },
  {
    "title": "Steffen Lang",
    "link": "https://www.novartis.com/about/executive-committee/steffen-lang",
    "timestamp": "unknown"
  },
  {
    "title": "Fiona Marshall",
    "link": "https://www.novartis.com/about/executive-committee/fiona-marshall",
    "timestamp": "unknown"
  },
  {
    "title": "Lutz Hegemann",
    "link": "https://www.novartis.com/about/executive-committee/lutz-hegemann",
    "timestamp": "unknown"
  },
  {
    "title": "Teresa Jose",
    "link": "https://www.novartis.com/about/executive-committee/teresa-jose",
    "timestamp": "unknown"
  },
  {
    "title": "Michelle Weese",
    "link": "https://www.novartis.com/about/executive-committee/michelle-weese",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://www.novartis.com/about/products",
    "timestamp": "unknown"
  },
  {
    "title": "Therapeutic areasCardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolic",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Immunology",
    "link": "https://www.novartis.com/about/therapeutic-areas/immunology",
    "timestamp": "unknown"
  },
  {
    "title": "Neuroscience",
    "link": "https://www.novartis.com/about/therapeutic-areas/neuroscience",
    "timestamp": "unknown"
  },
  {
    "title": "Oncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/oncology",
    "timestamp": "unknown"
  },
  {
    "title": "People and culture",
    "link": "https://www.novartis.com/about/people-and-culture",
    "timestamp": "unknown"
  },
  {
    "title": "InclusionPromoting inclusionBuilding belongingParental leaveCaring for the mental health and wellbeing of our people",
    "link": "https://www.novartis.com/about/inclusion",
    "timestamp": "unknown"
  },
  {
    "title": "Promoting inclusionBuilding belongingParental leaveCaring for the mental health and wellbeing of our people",
    "link": "https://www.novartis.com/about/inclusion/promoting-inclusion",
    "timestamp": "unknown"
  },
  {
    "title": "Promoting inclusionBuilding belongingParental leaveCaring for the mental health and wellbeing of our people",
    "link": "https://www.novartis.com/about/inclusion/promoting-inclusion",
    "timestamp": "unknown"
  },
  {
    "title": "Promoting inclusionBuilding belongingParental leaveCaring for the mental health and wellbeing of our people",
    "link": "https://www.novartis.com/about/inclusion/promoting-inclusion",
    "timestamp": "unknown"
  },
  {
    "title": "Promoting inclusionBuilding belongingParental leaveCaring for the mental health and wellbeing of our people",
    "link": "https://www.novartis.com/about/inclusion/promoting-inclusion",
    "timestamp": "unknown"
  },
  {
    "title": "Promoting inclusion",
    "link": "https://www.novartis.com/about/inclusion/promoting-inclusion",
    "timestamp": "unknown"
  },
  {
    "title": "Building belonging",
    "link": "https://www.novartis.com/about/inclusion/building-belonging",
    "timestamp": "unknown"
  },
  {
    "title": "Parental leave",
    "link": "https://www.novartis.com/about/inclusion/parental-leave",
    "timestamp": "unknown"
  },
  {
    "title": "Caring for the mental health and wellbeing of our people",
    "link": "https://www.novartis.com/about/inclusion/caring-mental-health-and-wellbeing-our-people",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Gene Therapies",
    "link": "https://www.novartis.com/about/novartis-gene-therapies",
    "timestamp": "unknown"
  },
  {
    "title": "Manufacturing",
    "link": "https://www.novartis.com/about/manufacturing",
    "timestamp": "unknown"
  },
  {
    "title": "QualityAudit programNovartis quality management system (QMS)Product and patient safety trainingRegulatory inspectionsProduct recallsThird-party suppli",
    "link": "https://www.novartis.com/about/quality",
    "timestamp": "unknown"
  },
  {
    "title": "Audit programNovartis quality management system (QMS)Product and patient safety trainingRegulatory inspectionsProduct recallsThird-party suppliers",
    "link": "https://www.novartis.com/about/quality/audit-program",
    "timestamp": "unknown"
  },
  {
    "title": "Audit programNovartis quality management system (QMS)Product and patient safety trainingRegulatory inspectionsProduct recallsThird-party suppliers",
    "link": "https://www.novartis.com/about/quality/audit-program",
    "timestamp": "unknown"
  },
  {
    "title": "Audit programNovartis quality management system (QMS)Product and patient safety trainingRegulatory inspectionsProduct recallsThird-party suppliers",
    "link": "https://www.novartis.com/about/quality/audit-program",
    "timestamp": "unknown"
  },
  {
    "title": "Audit programNovartis quality management system (QMS)Product and patient safety trainingRegulatory inspectionsProduct recallsThird-party suppliers",
    "link": "https://www.novartis.com/about/quality/audit-program",
    "timestamp": "unknown"
  },
  {
    "title": "Audit program",
    "link": "https://www.novartis.com/about/quality/audit-program",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis quality management system (QMS)",
    "link": "https://www.novartis.com/about/quality/novartis-quality-management-system-qms",
    "timestamp": "unknown"
  },
  {
    "title": "Product and patient safety training",
    "link": "https://www.novartis.com/about/quality/product-and-patient-safety-training",
    "timestamp": "unknown"
  },
  {
    "title": "Regulatory inspections",
    "link": "https://www.novartis.com/about/quality/regulatory-inspections",
    "timestamp": "unknown"
  },
  {
    "title": "Product recalls",
    "link": "https://www.novartis.com/about/quality/product-recalls",
    "timestamp": "unknown"
  },
  {
    "title": "Third-party suppliers",
    "link": "https://www.novartis.com/about/quality/third-party-suppliers",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis and the European Union (EU)",
    "link": "https://www.novartis.com/about/novartis-and-european-union",
    "timestamp": "unknown"
  },
  {
    "title": "Awards and recognition",
    "link": "https://www.novartis.com/about/awards-and-recognition",
    "timestamp": "unknown"
  },
  {
    "title": "Patients and caregiversNovartis commitment to patients and caregiversDiseasesPatient organization fundingPatients perspectives storiesPatients and car",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis commitment to patients and caregiversDiseasesPatient organization fundingPatients perspectives storiesPatients and caregiversInformation for ",
    "link": "https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis commitment to patients and caregiversDiseasesPatient organization fundingPatients perspectives storiesPatients and caregiversInformation for ",
    "link": "https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis commitment to patients and caregiversDiseasesPatient organization fundingPatients perspectives storiesPatients and caregiversInformation for ",
    "link": "https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis commitment to patients and caregiversDiseasesPatient organization fundingPatients perspectives stories",
    "link": "https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis commitment to patients and caregivers",
    "link": "https://www.novartis.com/patients-and-caregivers/novartis-commitment-patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Diseases",
    "link": "https://www.novartis.com/diseases",
    "timestamp": "unknown"
  },
  {
    "title": "Patient organization funding",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/patient-organization-funding",
    "timestamp": "unknown"
  },
  {
    "title": "Patients perspectives stories",
    "link": "https://www.novartis.com/news/stories/patient-perspectives",
    "timestamp": "unknown"
  },
  {
    "title": "Healthcare professionalsMedical congresses and eventsASCO Annual MeetingProductsNovartis pipelineManaged access programsZolgensma\u00ae Global Managed Acce",
    "link": "https://www.novartis.com/healthcare-professionals",
    "timestamp": "unknown"
  },
  {
    "title": "Medical congresses and eventsASCO Annual MeetingProductsNovartis pipelineManaged access programsZolgensma\u00ae Global Managed Access Program (gMAP)Novarti",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events",
    "timestamp": "unknown"
  },
  {
    "title": "Medical congresses and eventsASCO Annual MeetingProductsNovartis pipelineManaged access programsZolgensma\u00ae Global Managed Access Program (gMAP)Novarti",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events",
    "timestamp": "unknown"
  },
  {
    "title": "Medical congresses and eventsASCO Annual MeetingProductsNovartis pipelineManaged access programsZolgensma\u00ae Global Managed Access Program (gMAP)Novarti",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events",
    "timestamp": "unknown"
  },
  {
    "title": "Medical congresses and eventsASCO Annual MeetingProductsNovartis pipelineManaged access programsZolgensma\u00ae Global Managed Access Program (gMAP)Novarti",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events",
    "timestamp": "unknown"
  },
  {
    "title": "Medical congresses and eventsASCO Annual Meeting",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events",
    "timestamp": "unknown"
  },
  {
    "title": "ASCO Annual Meeting",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting",
    "timestamp": "unknown"
  },
  {
    "title": "ASCO Annual Meeting",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting",
    "timestamp": "unknown"
  },
  {
    "title": "ASCO Annual Meeting",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting",
    "timestamp": "unknown"
  },
  {
    "title": "ASCO Annual Meeting",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting",
    "timestamp": "unknown"
  },
  {
    "title": "ASCO Annual Meeting",
    "link": "https://www.novartis.com/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://www.novartis.com/about/products",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis pipeline",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "Managed access programsZolgensma\u00ae Global Managed Access Program (gMAP)",
    "link": "https://www.novartis.com/healthcare-professionals/managed-access-programs",
    "timestamp": "unknown"
  },
  {
    "title": "Zolgensma\u00ae Global Managed Access Program (gMAP)",
    "link": "https://www.novartis.com/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap",
    "timestamp": "unknown"
  },
  {
    "title": "Zolgensma\u00ae Global Managed Access Program (gMAP)",
    "link": "https://www.novartis.com/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap",
    "timestamp": "unknown"
  },
  {
    "title": "Zolgensma\u00ae Global Managed Access Program (gMAP)",
    "link": "https://www.novartis.com/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap",
    "timestamp": "unknown"
  },
  {
    "title": "Zolgensma\u00ae Global Managed Access Program (gMAP)",
    "link": "https://www.novartis.com/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap",
    "timestamp": "unknown"
  },
  {
    "title": "Zolgensma\u00ae Global Managed Access Program (gMAP)",
    "link": "https://www.novartis.com/healthcare-professionals/managed-access-programs/zolgensma-global-managed-access-program-gmap",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis external funding",
    "link": "https://www.novartis.com/healthcare-professionals/novartis-external-funding",
    "timestamp": "unknown"
  },
  {
    "title": "Healthcare professional resources by country",
    "link": "https://www.novartis.com/healthcare-professionals/healthcare-professional-resources-country",
    "timestamp": "unknown"
  },
  {
    "title": "Investigator-initiated trials / studies",
    "link": "https://www.novartis.com/healthcare-professionals/investigator-initiated-trials-studies-clinical-and-investigator-initiated-research-non-clinical",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis medical informationSubmit medical enquiry",
    "link": "https://www.novartis.com/healthcare-professionals/novartis-medical-information",
    "timestamp": "unknown"
  },
  {
    "title": "Submit medical enquiry",
    "link": "https://www.novartis.com/healthcare-professionals/novartis-medical-information/submit-medical-enquiry",
    "timestamp": "unknown"
  },
  {
    "title": "Submit medical enquiry",
    "link": "https://www.novartis.com/healthcare-professionals/novartis-medical-information/submit-medical-enquiry",
    "timestamp": "unknown"
  },
  {
    "title": "Submit medical enquiry",
    "link": "https://www.novartis.com/healthcare-professionals/novartis-medical-information/submit-medical-enquiry",
    "timestamp": "unknown"
  },
  {
    "title": "Submit medical enquiry",
    "link": "https://www.novartis.com/healthcare-professionals/novartis-medical-information/submit-medical-enquiry",
    "timestamp": "unknown"
  },
  {
    "title": "Submit medical enquiry",
    "link": "https://www.novartis.com/healthcare-professionals/novartis-medical-information/submit-medical-enquiry",
    "timestamp": "unknown"
  },
  {
    "title": "Research and developmentTechnology platformsResearch disease areasCardiovascular and metabolic disease research at NovartisDAx: exploratory disease re",
    "link": "https://www.novartis.com/research-and-development",
    "timestamp": "unknown"
  },
  {
    "title": "Technology platformsResearch disease areasCardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal",
    "link": "https://www.novartis.com/research-and-development/technology-platforms",
    "timestamp": "unknown"
  },
  {
    "title": "Technology platformsResearch disease areasCardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal",
    "link": "https://www.novartis.com/research-and-development/technology-platforms",
    "timestamp": "unknown"
  },
  {
    "title": "Technology platformsResearch disease areasCardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal",
    "link": "https://www.novartis.com/research-and-development/technology-platforms",
    "timestamp": "unknown"
  },
  {
    "title": "Technology platformsResearch disease areasCardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal",
    "link": "https://www.novartis.com/research-and-development/technology-platforms",
    "timestamp": "unknown"
  },
  {
    "title": "Technology platforms",
    "link": "https://www.novartis.com/research-and-development/technology-platforms",
    "timestamp": "unknown"
  },
  {
    "title": "Research disease areasCardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal Health disease area",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal Health disease area research at NovartisI",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal Health disease area research at NovartisI",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal Health disease area research at NovartisI",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular and metabolic disease research at NovartisDAx: exploratory disease research at NovartisGlobal Health disease area research at NovartisI",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular and metabolic disease research at Novartis",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/cardiovascular-and-metabolic-disease-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "DAx: exploratory disease research at Novartis",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/dax-exploratory-disease-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Global Health disease area research at Novartis",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/global-health-disease-area-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Immunology disease research at Novartis",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/immunology-disease-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Neuroscience research at Novartis",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/neuroscience-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Oncology research at Novartis",
    "link": "https://www.novartis.com/research-and-development/research-disease-areas/oncology-research-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis pipeline",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "Research collaborations",
    "link": "https://www.novartis.com/research-and-development/research-collaborations",
    "timestamp": "unknown"
  },
  {
    "title": "Collaborations",
    "link": "https://www.novartis.com/research-and-development/collaborations",
    "timestamp": "unknown"
  },
  {
    "title": "ESGAccessCreating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents a",
    "link": "https://www.novartis.com/esg",
    "timestamp": "unknown"
  },
  {
    "title": "AccessCreating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and ",
    "link": "https://www.novartis.com/esg/access",
    "timestamp": "unknown"
  },
  {
    "title": "AccessCreating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and ",
    "link": "https://www.novartis.com/esg/access",
    "timestamp": "unknown"
  },
  {
    "title": "AccessCreating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and ",
    "link": "https://www.novartis.com/esg/access",
    "timestamp": "unknown"
  },
  {
    "title": "AccessCreating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and ",
    "link": "https://www.novartis.com/esg/access",
    "timestamp": "unknown"
  },
  {
    "title": "AccessCreating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and ",
    "link": "https://www.novartis.com/esg/access",
    "timestamp": "unknown"
  },
  {
    "title": "Creating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and licens",
    "link": "https://www.novartis.com/esg/access/creating-sustainable-business-models",
    "timestamp": "unknown"
  },
  {
    "title": "Creating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and licens",
    "link": "https://www.novartis.com/esg/access/creating-sustainable-business-models",
    "timestamp": "unknown"
  },
  {
    "title": "Creating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and licens",
    "link": "https://www.novartis.com/esg/access/creating-sustainable-business-models",
    "timestamp": "unknown"
  },
  {
    "title": "Creating sustainable business modelsValue-based pricingSub-Saharan AfricaDonationsNovartis access principlesNovartis oncology accessPatents and licens",
    "link": "https://www.novartis.com/esg/access/creating-sustainable-business-models",
    "timestamp": "unknown"
  },
  {
    "title": "Creating sustainable business models",
    "link": "https://www.novartis.com/esg/access/creating-sustainable-business-models",
    "timestamp": "unknown"
  },
  {
    "title": "Value-based pricing",
    "link": "https://www.novartis.com/esg/access/value-based-pricing",
    "timestamp": "unknown"
  },
  {
    "title": "Sub-Saharan Africa",
    "link": "https://www.novartis.com/esg/access/sub-saharan-africa",
    "timestamp": "unknown"
  },
  {
    "title": "Donations",
    "link": "https://www.novartis.com/esg/access/donations",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis access principles",
    "link": "https://www.novartis.com/esg/access/novartis-access-principles",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis oncology access",
    "link": "https://www.novartis.com/esg/access/novartis-oncology-access",
    "timestamp": "unknown"
  },
  {
    "title": "Patents and licensing",
    "link": "https://www.novartis.com/esg/access/patents-and-licensing",
    "timestamp": "unknown"
  },
  {
    "title": "Environmental sustainabilityClimateNature - WasteNature - Water",
    "link": "https://www.novartis.com/esg/environmental-sustainability",
    "timestamp": "unknown"
  },
  {
    "title": "ClimateNature - WasteNature - Water",
    "link": "https://www.novartis.com/esg/environmental-sustainability/climate",
    "timestamp": "unknown"
  },
  {
    "title": "ClimateNature - WasteNature - Water",
    "link": "https://www.novartis.com/esg/environmental-sustainability/climate",
    "timestamp": "unknown"
  },
  {
    "title": "ClimateNature - WasteNature - Water",
    "link": "https://www.novartis.com/esg/environmental-sustainability/climate",
    "timestamp": "unknown"
  },
  {
    "title": "ClimateNature - WasteNature - Water",
    "link": "https://www.novartis.com/esg/environmental-sustainability/climate",
    "timestamp": "unknown"
  },
  {
    "title": "Climate",
    "link": "https://www.novartis.com/esg/environmental-sustainability/climate",
    "timestamp": "unknown"
  },
  {
    "title": "Nature - Waste",
    "link": "https://www.novartis.com/esg/environmental-sustainability/waste",
    "timestamp": "unknown"
  },
  {
    "title": "Nature - Water",
    "link": "https://www.novartis.com/esg/environmental-sustainability/water",
    "timestamp": "unknown"
  },
  {
    "title": "Ethics, risk and complianceEthical behaviorComplianceHuman rightsLearning and engagementIntegrated risk assurance",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance",
    "timestamp": "unknown"
  },
  {
    "title": "Ethical behaviorComplianceHuman rightsLearning and engagementIntegrated risk assurance",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior",
    "timestamp": "unknown"
  },
  {
    "title": "Ethical behaviorComplianceHuman rightsLearning and engagementIntegrated risk assurance",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior",
    "timestamp": "unknown"
  },
  {
    "title": "Ethical behaviorComplianceHuman rightsLearning and engagementIntegrated risk assurance",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior",
    "timestamp": "unknown"
  },
  {
    "title": "Ethical behaviorComplianceHuman rightsLearning and engagementIntegrated risk assurance",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior",
    "timestamp": "unknown"
  },
  {
    "title": "Ethical behavior",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior",
    "timestamp": "unknown"
  },
  {
    "title": "Compliance",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/compliance",
    "timestamp": "unknown"
  },
  {
    "title": "Human rights",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/human-rights",
    "timestamp": "unknown"
  },
  {
    "title": "Learning and engagement",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/learning-and-engagement",
    "timestamp": "unknown"
  },
  {
    "title": "Integrated risk assurance",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/integrated-risk-assurance",
    "timestamp": "unknown"
  },
  {
    "title": "Global healthPandemic preparednessAvoidable blindnessChagas diseaseLeprosyMalariaSickle cell disease (SCD)Novartis Foundation",
    "link": "https://www.novartis.com/esg/global-health",
    "timestamp": "unknown"
  },
  {
    "title": "Pandemic preparednessAvoidable blindnessChagas diseaseLeprosyMalariaSickle cell disease (SCD)Novartis Foundation",
    "link": "https://www.novartis.com/esg/global-health/pandemic-preparedness",
    "timestamp": "unknown"
  },
  {
    "title": "Pandemic preparednessAvoidable blindnessChagas diseaseLeprosyMalariaSickle cell disease (SCD)Novartis Foundation",
    "link": "https://www.novartis.com/esg/global-health/pandemic-preparedness",
    "timestamp": "unknown"
  },
  {
    "title": "Pandemic preparednessAvoidable blindnessChagas diseaseLeprosyMalariaSickle cell disease (SCD)Novartis Foundation",
    "link": "https://www.novartis.com/esg/global-health/pandemic-preparedness",
    "timestamp": "unknown"
  },
  {
    "title": "Pandemic preparednessAvoidable blindnessChagas diseaseLeprosyMalariaSickle cell disease (SCD)Novartis Foundation",
    "link": "https://www.novartis.com/esg/global-health/pandemic-preparedness",
    "timestamp": "unknown"
  },
  {
    "title": "Pandemic preparedness",
    "link": "https://www.novartis.com/esg/global-health/pandemic-preparedness",
    "timestamp": "unknown"
  },
  {
    "title": "Avoidable blindness",
    "link": "https://www.novartis.com/esg/global-health/avoidable-blindness",
    "timestamp": "unknown"
  },
  {
    "title": "Chagas disease",
    "link": "https://www.novartis.com/diseases/chagas-disease",
    "timestamp": "unknown"
  },
  {
    "title": "Leprosy",
    "link": "https://www.novartis.com/diseases/leprosy",
    "timestamp": "unknown"
  },
  {
    "title": "Malaria",
    "link": "https://www.novartis.com/diseases/malaria",
    "timestamp": "unknown"
  },
  {
    "title": "Sickle cell disease (SCD)",
    "link": "https://www.novartis.com/diseases/sickle-cell-disease",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Foundation",
    "link": "https://www.novartisfoundation.org/",
    "timestamp": "unknown"
  },
  {
    "title": "Inclusion",
    "link": "https://www.novartis.com/about/inclusion",
    "timestamp": "unknown"
  },
  {
    "title": "ESG index",
    "link": "https://www.novartis.com/esg/index",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting and transparency hubESG rating performanceTargetsPatient organization fundingPayments to healthcare professionalsPublic policyA living wageA",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub",
    "timestamp": "unknown"
  },
  {
    "title": "ESG rating performanceTargetsPatient organization fundingPayments to healthcare professionalsPublic policyA living wageA safe workplaceAnimal research",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance",
    "timestamp": "unknown"
  },
  {
    "title": "ESG rating performanceTargetsPatient organization fundingPayments to healthcare professionalsPublic policyA living wageA safe workplaceAnimal research",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance",
    "timestamp": "unknown"
  },
  {
    "title": "ESG rating performanceTargetsPatient organization fundingPayments to healthcare professionalsPublic policyA living wageA safe workplaceAnimal research",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance",
    "timestamp": "unknown"
  },
  {
    "title": "ESG rating performanceTargetsPatient organization fundingPayments to healthcare professionalsPublic policyA living wageA safe workplaceAnimal research",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance",
    "timestamp": "unknown"
  },
  {
    "title": "ESG rating performance",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance",
    "timestamp": "unknown"
  },
  {
    "title": "Targets",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/targets",
    "timestamp": "unknown"
  },
  {
    "title": "Patient organization funding",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/patient-organization-funding",
    "timestamp": "unknown"
  },
  {
    "title": "Payments to healthcare professionals",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/payments-healthcare-professionals",
    "timestamp": "unknown"
  },
  {
    "title": "Public policy",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/public-policy",
    "timestamp": "unknown"
  },
  {
    "title": "A living wage",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/living-wage",
    "timestamp": "unknown"
  },
  {
    "title": "A safe workplace",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/safe-workplace",
    "timestamp": "unknown"
  },
  {
    "title": "Animal research",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/animal-research",
    "timestamp": "unknown"
  },
  {
    "title": "InvestorsEvent calendarFinancial dataNovartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected",
    "link": "https://www.novartis.com/investors",
    "timestamp": "unknown"
  },
  {
    "title": "Event calendarFinancial dataNovartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency",
    "link": "https://www.novartis.com/investors/event-calendar",
    "timestamp": "unknown"
  },
  {
    "title": "Event calendarFinancial dataNovartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency",
    "link": "https://www.novartis.com/investors/event-calendar",
    "timestamp": "unknown"
  },
  {
    "title": "Event calendarFinancial dataNovartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency",
    "link": "https://www.novartis.com/investors/event-calendar",
    "timestamp": "unknown"
  },
  {
    "title": "Event calendarFinancial dataNovartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency",
    "link": "https://www.novartis.com/investors/event-calendar",
    "timestamp": "unknown"
  },
  {
    "title": "Event calendar",
    "link": "https://www.novartis.com/investors/event-calendar",
    "timestamp": "unknown"
  },
  {
    "title": "Financial dataNovartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency impact",
    "link": "https://www.novartis.com/investors/financial-data",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency impact",
    "link": "https://www.novartis.com/investors/financial-data/annual-results",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency impact",
    "link": "https://www.novartis.com/investors/financial-data/annual-results",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency impact",
    "link": "https://www.novartis.com/investors/financial-data/annual-results",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis annual resultsNovartis quarterly resultsNovartis SEC filingsProduct salesFixed-income securitiesExpected currency impact",
    "link": "https://www.novartis.com/investors/financial-data/annual-results",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis annual results",
    "link": "https://www.novartis.com/investors/financial-data/annual-results",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis quarterly results",
    "link": "https://www.novartis.com/investors/financial-data/quarterly-results",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis SEC filings",
    "link": "https://www.novartis.com/investors/financial-data/sec-filings",
    "timestamp": "unknown"
  },
  {
    "title": "Product sales",
    "link": "https://www.novartis.com/investors/financial-data/product-sales",
    "timestamp": "unknown"
  },
  {
    "title": "Fixed-income securities",
    "link": "https://www.novartis.com/investors/financial-data/fixed-income-securities",
    "timestamp": "unknown"
  },
  {
    "title": "Expected currency impact",
    "link": "https://www.novartis.com/investors/financial-data/expected-currency-impact",
    "timestamp": "unknown"
  },
  {
    "title": "Share data and analysisShare monitorDividend informationShare ownershipShare overviewReturn on investment calculator",
    "link": "https://www.novartis.com/investors/share-data-and-analysis",
    "timestamp": "unknown"
  },
  {
    "title": "Share monitorDividend informationShare ownershipShare overviewReturn on investment calculator",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/share-monitor",
    "timestamp": "unknown"
  },
  {
    "title": "Share monitorDividend informationShare ownershipShare overviewReturn on investment calculator",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/share-monitor",
    "timestamp": "unknown"
  },
  {
    "title": "Share monitorDividend informationShare ownershipShare overviewReturn on investment calculator",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/share-monitor",
    "timestamp": "unknown"
  },
  {
    "title": "Share monitorDividend informationShare ownershipShare overviewReturn on investment calculator",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/share-monitor",
    "timestamp": "unknown"
  },
  {
    "title": "Share monitor",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/share-monitor",
    "timestamp": "unknown"
  },
  {
    "title": "Dividend information",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/dividend-information",
    "timestamp": "unknown"
  },
  {
    "title": "Share ownership",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/share-ownership",
    "timestamp": "unknown"
  },
  {
    "title": "Share overview",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/share-overview",
    "timestamp": "unknown"
  },
  {
    "title": "Return on investment calculator",
    "link": "https://www.novartis.com/investors/share-data-and-analysis/return-investment-calculator",
    "timestamp": "unknown"
  },
  {
    "title": "Shareholder informationGeneral MeetingsAmerican Depositary Receipts (ADR)Share buybackFrequently asked questions",
    "link": "https://www.novartis.com/investors/shareholder-information",
    "timestamp": "unknown"
  },
  {
    "title": "General MeetingsAmerican Depositary Receipts (ADR)Share buybackFrequently asked questions",
    "link": "https://www.novartis.com/investors/shareholder-information/general-meetings",
    "timestamp": "unknown"
  },
  {
    "title": "General MeetingsAmerican Depositary Receipts (ADR)Share buybackFrequently asked questions",
    "link": "https://www.novartis.com/investors/shareholder-information/general-meetings",
    "timestamp": "unknown"
  },
  {
    "title": "General MeetingsAmerican Depositary Receipts (ADR)Share buybackFrequently asked questions",
    "link": "https://www.novartis.com/investors/shareholder-information/general-meetings",
    "timestamp": "unknown"
  },
  {
    "title": "General MeetingsAmerican Depositary Receipts (ADR)Share buybackFrequently asked questions",
    "link": "https://www.novartis.com/investors/shareholder-information/general-meetings",
    "timestamp": "unknown"
  },
  {
    "title": "General Meetings",
    "link": "https://www.novartis.com/investors/shareholder-information/general-meetings",
    "timestamp": "unknown"
  },
  {
    "title": "American Depositary Receipts (ADR)",
    "link": "https://www.novartis.com/investors/shareholder-information/american-depositary-receipts-adr",
    "timestamp": "unknown"
  },
  {
    "title": "Share buyback",
    "link": "https://www.novartis.com/investors/shareholder-information/share-buy-back",
    "timestamp": "unknown"
  },
  {
    "title": "Frequently asked questions",
    "link": "https://www.novartis.com/investors/shareholder-information/frequently-asked-questions",
    "timestamp": "unknown"
  },
  {
    "title": "Company overviewCorporate governance",
    "link": "https://www.novartis.com/investors/company-overview",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate governance",
    "link": "https://www.novartis.com/investors/company-overview/corporate-governance",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate governance",
    "link": "https://www.novartis.com/investors/company-overview/corporate-governance",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate governance",
    "link": "https://www.novartis.com/investors/company-overview/corporate-governance",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate governance",
    "link": "https://www.novartis.com/investors/company-overview/corporate-governance",
    "timestamp": "unknown"
  },
  {
    "title": "Corporate governance",
    "link": "https://www.novartis.com/investors/company-overview/corporate-governance",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting and transparency hubReporting archiveESG rating performancePublications order form",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting archiveESG rating performancePublications order form",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/reporting-archive",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting archiveESG rating performancePublications order form",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/reporting-archive",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting archiveESG rating performancePublications order form",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/reporting-archive",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting archiveESG rating performancePublications order form",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/reporting-archive",
    "timestamp": "unknown"
  },
  {
    "title": "Reporting archive",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/reporting-archive",
    "timestamp": "unknown"
  },
  {
    "title": "ESG rating performance",
    "link": "https://www.novartis.com/investors/reporting-and-transparency-hub/esg-rating-performance",
    "timestamp": "unknown"
  },
  {
    "title": "Publications order form",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "ESG",
    "link": "https://www.novartis.com/esg",
    "timestamp": "unknown"
  },
  {
    "title": "NewsNewsroomMedia libraryStoriesSubscribeEventsNewsInformation for journalists including media releases, statements, stories, multimedia resources and",
    "link": "https://www.novartis.com/news",
    "timestamp": "unknown"
  },
  {
    "title": "NewsroomMedia libraryStoriesSubscribeEventsNewsInformation for journalists including media releases, statements, stories, multimedia resources and mor",
    "link": "https://www.novartis.com/news/newsroom",
    "timestamp": "unknown"
  },
  {
    "title": "NewsroomMedia libraryStoriesSubscribeEventsNewsInformation for journalists including media releases, statements, stories, multimedia resources and mor",
    "link": "https://www.novartis.com/news/newsroom",
    "timestamp": "unknown"
  },
  {
    "title": "NewsroomMedia libraryStoriesSubscribeEventsNewsInformation for journalists including media releases, statements, stories, multimedia resources and mor",
    "link": "https://www.novartis.com/news/newsroom",
    "timestamp": "unknown"
  },
  {
    "title": "NewsroomMedia libraryStoriesSubscribeEvents",
    "link": "https://www.novartis.com/news/newsroom",
    "timestamp": "unknown"
  },
  {
    "title": "Newsroom",
    "link": "https://www.novartis.com/news/newsroom",
    "timestamp": "unknown"
  },
  {
    "title": "Media library",
    "link": "https://www.novartis.com/news/media-library",
    "timestamp": "unknown"
  },
  {
    "title": "Stories",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Events",
    "link": "https://www.novartis.com/events",
    "timestamp": "unknown"
  },
  {
    "title": "CareersCareer searchOur business functionsCareers in research and developmentCareers in operationsCareers in commercial and salesCareers in global fun",
    "link": "https://www.novartis.com/careers",
    "timestamp": "unknown"
  },
  {
    "title": "Career searchOur business functionsCareers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functionsW",
    "link": "https://www.novartis.com/careers/career-search",
    "timestamp": "unknown"
  },
  {
    "title": "Career searchOur business functionsCareers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functionsW",
    "link": "https://www.novartis.com/careers/career-search",
    "timestamp": "unknown"
  },
  {
    "title": "Career searchOur business functionsCareers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functionsW",
    "link": "https://www.novartis.com/careers/career-search",
    "timestamp": "unknown"
  },
  {
    "title": "Career searchOur business functionsCareers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functionsW",
    "link": "https://www.novartis.com/careers/career-search",
    "timestamp": "unknown"
  },
  {
    "title": "Career search",
    "link": "https://www.novartis.com/careers/career-search",
    "timestamp": "unknown"
  },
  {
    "title": "Our business functionsCareers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functions",
    "link": "https://www.novartis.com/careers/our-business-functions",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functions",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-research-and-development",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functions",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-research-and-development",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functions",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-research-and-development",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in research and developmentCareers in operationsCareers in commercial and salesCareers in global functions",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-research-and-development",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in research and development",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-research-and-development",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in operations",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-operations",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in commercial and sales",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales",
    "timestamp": "unknown"
  },
  {
    "title": "Careers in global functions",
    "link": "https://www.novartis.com/careers/our-business-functions/careers-global-functions",
    "timestamp": "unknown"
  },
  {
    "title": "Why Novartis",
    "link": "https://www.novartis.com/careers/why-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "Career hubTemporary contracts",
    "link": "https://www.novartis.com/careers/career-hub",
    "timestamp": "unknown"
  },
  {
    "title": "Temporary contracts",
    "link": "https://novartis.willhire.co",
    "timestamp": "unknown"
  },
  {
    "title": "Temporary contracts",
    "link": "https://novartis.willhire.co",
    "timestamp": "unknown"
  },
  {
    "title": "Temporary contracts",
    "link": "https://novartis.willhire.co",
    "timestamp": "unknown"
  },
  {
    "title": "Temporary contracts",
    "link": "https://novartis.willhire.co",
    "timestamp": "unknown"
  },
  {
    "title": "Temporary contracts",
    "link": "https://novartis.willhire.co",
    "timestamp": "unknown"
  },
  {
    "title": "Early careersGraduatesStudentsUS Biomedical Research internship programsCommunity exploration and learning lab (CELL)",
    "link": "https://www.novartis.com/careers/early-careers",
    "timestamp": "unknown"
  },
  {
    "title": "GraduatesStudentsUS Biomedical Research internship programsCommunity exploration and learning lab (CELL)",
    "link": "https://www.novartis.com/careers/early-careers/graduates",
    "timestamp": "unknown"
  },
  {
    "title": "GraduatesStudentsUS Biomedical Research internship programsCommunity exploration and learning lab (CELL)",
    "link": "https://www.novartis.com/careers/early-careers/graduates",
    "timestamp": "unknown"
  },
  {
    "title": "GraduatesStudentsUS Biomedical Research internship programsCommunity exploration and learning lab (CELL)",
    "link": "https://www.novartis.com/careers/early-careers/graduates",
    "timestamp": "unknown"
  },
  {
    "title": "GraduatesStudentsUS Biomedical Research internship programsCommunity exploration and learning lab (CELL)",
    "link": "https://www.novartis.com/careers/early-careers/graduates",
    "timestamp": "unknown"
  },
  {
    "title": "Graduates",
    "link": "https://www.novartis.com/careers/early-careers/graduates",
    "timestamp": "unknown"
  },
  {
    "title": "Students",
    "link": "https://www.novartis.com/careers/early-careers/students",
    "timestamp": "unknown"
  },
  {
    "title": "US Biomedical Research internship programs",
    "link": "https://www.novartis.com/careers/early-careers/us-biomedical-research-internship-programs",
    "timestamp": "unknown"
  },
  {
    "title": "Community exploration and learning lab (CELL)",
    "link": "https://www.novartis.com/careers/early-careers/community-exploration-and-learning-lab-cell",
    "timestamp": "unknown"
  },
  {
    "title": "Clinical trials",
    "link": "https://www.novartis.com/clinicaltrials",
    "timestamp": "unknown"
  },
  {
    "title": "Partnering",
    "link": "https://www.novartis.com/partnering",
    "timestamp": "unknown"
  },
  {
    "title": "Supplier portal",
    "link": "https://www.novartis.com/supplier-portal",
    "timestamp": "unknown"
  },
  {
    "title": "Report side effects",
    "link": "https://www.novartis.com/report",
    "timestamp": "unknown"
  },
  {
    "title": "Contacts",
    "link": "https://www.novartis.com/contacts",
    "timestamp": "unknown"
  },
  {
    "title": "HeaderNewsroomNews and more from the frontiers of medicine.Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.D",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryN",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Date Range- Any -In The NewsPress ReleaseFeatured NewsStoryNews Type FiltersLanguage- Any -EnglishGermanFrenchStart DateEnd DateAllPress releasesAd ho",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "AllPress releasesAd hoc releasesStatementsStoriesAd hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch r",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "All",
    "link": "https://www.novartis.com/news#tab-all",
    "timestamp": "unknown"
  },
  {
    "title": "Press releases",
    "link": "https://www.novartis.com/news#tab-press-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releases",
    "link": "https://www.novartis.com/news#tab-ad-hoc-releases",
    "timestamp": "unknown"
  },
  {
    "title": "Statements",
    "link": "https://www.novartis.com/news#tab-statements",
    "timestamp": "unknown"
  },
  {
    "title": "Stories",
    "link": "https://www.novartis.com/news#tab-stories",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income gu",
    "link": "https://www.novartis.com/news/media-releases/novartis-reports-strong-q2-double-digit-sales-growth-and-core-margin-expansion-raises-fy-2025-core-operating-income-guidance",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJul 08, 2025Novartis receives approval for first malaria medicine for newborn babies and young infantsCoartem\u00ae (artemether-lumefantrine) ",
    "link": "https://www.novartis.com/news/media-releases/novartis-receives-approval-first-malaria-medicine-newborn-babies-and-young-infants",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJul 03, 2025Novartis provides update on Phase III GCAptAIN study of Cosentyx\u00ae in giant cell arteritis (GCA)The GCAptAIN study did not mee",
    "link": "https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-gcaptain-study-cosentyx-giant-cell-arteritis-gca",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 25, 2025Novartis completes acquisition of Regulus TherapeuticsBasel, June 25, 2025 \u2013 Novartis today announced that it has successfull",
    "link": "https://www.novartis.com/news/media-releases/novartis-completes-acquisition-regulus-therapeutics",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 25, 2025Novartis announces expiration of Regulus Therapeutics tender offerBasel, June 25, 2025 \u2013 Novartis today announced that its pr",
    "link": "https://www.novartis.com/news/media-releases/novartis-announces-expiration-regulus-therapeutics-tender-offer",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 23, 2025Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offerBasel, June 23, 2025 \u2013 Novartis today",
    "link": "https://www.novartis.com/news/media-releases/novartis-announces-expiration-hsr-waiting-period-regulus-therapeutics-tender-offer",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 12, 2025Novartis Fabhalta\u00ae shows statistically significant and clinically meaningful improvements in hemoglobin in new population of ",
    "link": "https://www.novartis.com/news/media-releases/novartis-fabhalta-shows-statistically-significant-and-clinically-meaningful-improvements-hemoglobin-new-population-patients-pnh",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJun 02, 2025Novartis Pluvicto\u2122 demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-posit",
    "link": "https://www.novartis.com/news/media-releases/novartis-pluvictotm-demonstrates-statistically-significant-and-clinically-meaningful-rpfs-benefit-patients-psma-positive-metastatic-hormone-sensitive-prostate-cancer",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 01, 2025Novartis Kisqali\u00ae reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis33% red",
    "link": "https://www.novartis.com/news/media-releases/novartis-kisqali-reduces-risk-recurrence-younger-patients-early-breast-cancer-natalee-subgroup-analysis",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseMay 27, 2025Novartis announces commencement of tender offer to acquire Regulus TherapeuticsBasel, May 27, 2025 - Novartis today announced",
    "link": "https://www.novartis.com/news/media-releases/novartis-announces-commencement-tender-offer-acquire-regulus-therapeutics",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 22, 2025Access to HealthcareWhy advocating for your MS is so important",
    "link": "https://www.novartis.com/stories/why-advocating-your-ms-so-important",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income gu",
    "link": "https://www.novartis.com/news/media-releases/novartis-reports-strong-q2-double-digit-sales-growth-and-core-margin-expansion-raises-fy-2025-core-operating-income-guidance",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJul 08, 2025Novartis receives approval for first malaria medicine for newborn babies and young infantsCoartem\u00ae (artemether-lumefantrine) ",
    "link": "https://www.novartis.com/news/media-releases/novartis-receives-approval-first-malaria-medicine-newborn-babies-and-young-infants",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJul 03, 2025Novartis provides update on Phase III GCAptAIN study of Cosentyx\u00ae in giant cell arteritis (GCA)The GCAptAIN study did not mee",
    "link": "https://www.novartis.com/news/media-releases/novartis-provides-update-phase-iii-gcaptain-study-cosentyx-giant-cell-arteritis-gca",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 25, 2025Novartis completes acquisition of Regulus TherapeuticsBasel, June 25, 2025 \u2013 Novartis today announced that it has successfull",
    "link": "https://www.novartis.com/news/media-releases/novartis-completes-acquisition-regulus-therapeutics",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 25, 2025Novartis announces expiration of Regulus Therapeutics tender offerBasel, June 25, 2025 \u2013 Novartis today announced that its pr",
    "link": "https://www.novartis.com/news/media-releases/novartis-announces-expiration-regulus-therapeutics-tender-offer",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 23, 2025Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offerBasel, June 23, 2025 \u2013 Novartis today",
    "link": "https://www.novartis.com/news/media-releases/novartis-announces-expiration-hsr-waiting-period-regulus-therapeutics-tender-offer",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 12, 2025Novartis Fabhalta\u00ae shows statistically significant and clinically meaningful improvements in hemoglobin in new population of ",
    "link": "https://www.novartis.com/news/media-releases/novartis-fabhalta-shows-statistically-significant-and-clinically-meaningful-improvements-hemoglobin-new-population-patients-pnh",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJun 02, 2025Novartis Pluvicto\u2122 demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-posit",
    "link": "https://www.novartis.com/news/media-releases/novartis-pluvictotm-demonstrates-statistically-significant-and-clinically-meaningful-rpfs-benefit-patients-psma-positive-metastatic-hormone-sensitive-prostate-cancer",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseJun 01, 2025Novartis Kisqali\u00ae reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis33% red",
    "link": "https://www.novartis.com/news/media-releases/novartis-kisqali-reduces-risk-recurrence-younger-patients-early-breast-cancer-natalee-subgroup-analysis",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseMay 27, 2025Novartis announces commencement of tender offer to acquire Regulus TherapeuticsBasel, May 27, 2025 - Novartis today announced",
    "link": "https://www.novartis.com/news/media-releases/novartis-announces-commencement-tender-offer-acquire-regulus-therapeutics",
    "timestamp": "unknown"
  },
  {
    "title": "Press releaseMay 15, 2025New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipelineNATALEE subanalysis evalua",
    "link": "https://www.novartis.com/news/media-releases/new-novartis-data-asco-and-eha-showcase-momentum-pioneering-portfolio-promising-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the companyAd hoc anno",
    "link": "https://www.novartis.com/news/media-releases/novartis-appoints-mukul-mehta-chief-financial-officer-harry-kirsch-retires-after-22-years-company",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJul 17, 2025Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income gu",
    "link": "https://www.novartis.com/news/media-releases/novartis-reports-strong-q2-double-digit-sales-growth-and-core-margin-expansion-raises-fy-2025-core-operating-income-guidance",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJun 02, 2025Novartis Pluvicto\u2122 demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-posit",
    "link": "https://www.novartis.com/news/media-releases/novartis-pluvictotm-demonstrates-statistically-significant-and-clinically-meaningful-rpfs-benefit-patients-psma-positive-metastatic-hormone-sensitive-prostate-cancer",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseApr 29, 2025Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1Ad ho",
    "link": "https://www.novartis.com/news/media-releases/novartis-continues-strong-momentum-double-digit-sales-growth-robust-margin-expansion-and-multiple-approvals-q1",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseApr 03, 2025Novartis receives FDA accelerated approval for Vanrafia\u00ae (atrasentan), the first and only selective endothelin A receptor an",
    "link": "https://www.novartis.com/news/media-releases/novartis-receives-fda-accelerated-approval-vanrafia-atrasentan-first-and-only-selective-endothelin-receptor-antagonist-proteinuria-reduction-primary-iga-nephropathy-igan",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseMar 28, 2025FDA approves Novartis radioligand therapy Pluvicto\u00ae for earlier use before chemotherapy in PSMA-positive metastatic castrati",
    "link": "https://www.novartis.com/news/media-releases/fda-approves-novartis-radioligand-therapy-pluvicto-earlier-use-chemotherapy-psma-positive-metastatic-castration-resistant-prostate-cancer",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJan 31, 2025Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024Ad hoc an",
    "link": "https://www.novartis.com/news/media-releases/novartis-continues-strong-momentum-sales-growth-margin-expansion-reaches-key-innovation-milestones-2024",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseJan 31, 2025Novartis setzt die starke Umsatzdynamik mit Margenerh\u00f6hungen fort und erreicht 2024 wichtige Meilensteine bei InnovationenAd",
    "link": "https://www.novartis.com/news/media-releases/novartis-setzt-die-starke-umsatzdynamik-mit-margenerhohungen-fort-und-erreicht-2024-wichtige-meilensteine-bei-innovationen",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseDec 30, 2024Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMAAd",
    "link": "https://www.novartis.com/news/media-releases/novartis-intrathecal-onasemnogene-abeparvovec-phase-iii-study-meets-primary-endpoint-children-and-young-adults-sma",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseNov 21, 2024Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growthAd hoc a",
    "link": "https://www.novartis.com/news/media-releases/novartis-upgrades-mid-term-guidance-and-highlights-deep-pipeline-core-therapeutic-areas-drive-long-term-growth",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseOct 29, 2024Novartis Scemblix\u00ae FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability pr",
    "link": "https://www.novartis.com/news/media-releases/novartis-scemblix-fda-approved-newly-diagnosed-cml-offering-superior-efficacy-and-favorable-safety-and-tolerability-profile",
    "timestamp": "unknown"
  },
  {
    "title": "Ad hoc releaseOct 29, 2024Novartis continues strong momentum in Q3 with 10% sales growth, 20% core operating income growth, and important innovation m",
    "link": "https://www.novartis.com/news/media-releases/novartis-continues-strong-momentum-q3-10-sales-growth-20-core-operating-income-growth-and-important-innovation-milestones-raises-fy-2024-guidance",
    "timestamp": "unknown"
  },
  {
    "title": "StatementMay 08, 2025Vas Narasimhan named to 2025 TIME100 Health listStatementApr 25, 2025Europe talks health sovereignty \u2014 now it must deliverStateme",
    "link": "https://www.novartis.com/news/vas-narasimhan-named-2025-time100-health-list",
    "timestamp": "unknown"
  },
  {
    "title": "StatementMay 08, 2025Vas Narasimhan named to 2025 TIME100 Health listStatementApr 25, 2025Europe talks health sovereignty \u2014 now it must deliverStateme",
    "link": "https://www.novartis.com/news/vas-narasimhan-named-2025-time100-health-list",
    "timestamp": "unknown"
  },
  {
    "title": "StatementMay 08, 2025Vas Narasimhan named to 2025 TIME100 Health listStatementApr 25, 2025Europe talks health sovereignty \u2014 now it must deliverStateme",
    "link": "https://www.novartis.com/news/vas-narasimhan-named-2025-time100-health-list",
    "timestamp": "unknown"
  },
  {
    "title": "StatementMay 08, 2025Vas Narasimhan named to 2025 TIME100 Health listStatementApr 25, 2025Europe talks health sovereignty \u2014 now it must deliverStateme",
    "link": "https://www.novartis.com/news/vas-narasimhan-named-2025-time100-health-list",
    "timestamp": "unknown"
  },
  {
    "title": "StatementMay 08, 2025Vas Narasimhan named to 2025 TIME100 Health list",
    "link": "https://www.novartis.com/news/vas-narasimhan-named-2025-time100-health-list",
    "timestamp": "unknown"
  },
  {
    "title": "StatementApr 25, 2025Europe talks health sovereignty \u2014 now it must deliver",
    "link": "https://www.novartis.com/news/europe-talks-health-sovereignty-now-it-must-deliver",
    "timestamp": "unknown"
  },
  {
    "title": "StatementAug 15, 2024Novartis statement on Maximum Fair Price for Entresto",
    "link": "https://www.novartis.com/news/novartis-statement-maximum-fair-price-entresto",
    "timestamp": "unknown"
  },
  {
    "title": "StatementOct 19, 2023Violence against innocent people runs counter to our work to improve human health",
    "link": "https://www.novartis.com/news/violence-against-innocent-people-runs-counter-our-work-improve-human-health",
    "timestamp": "unknown"
  },
  {
    "title": "StatementOct 13, 2023Novartis condemns the terrorist actions against people in Israel and loss of innocent lives",
    "link": "https://www.novartis.com/news/novartis-condemns-terrorist-actions-against-people-israel-and-loss-innocent-lives",
    "timestamp": "unknown"
  },
  {
    "title": "StatementSep 19, 2023Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.Novartis and BeiGene, Ltd. have mutu",
    "link": "https://www.novartis.com/news/novartis-statement-collaboration-and-license-agreement-tislelizumab-beigene-ltd",
    "timestamp": "unknown"
  },
  {
    "title": "StatementSep 13, 2023Novartis provides support for Moroccan earthquake victims",
    "link": "https://www.novartis.com/news/novartis-provides-support-moroccan-earthquake-victims",
    "timestamp": "unknown"
  },
  {
    "title": "StatementSep 11, 2023GT005 (PPY988): Development Program in Geographic Atrophy",
    "link": "https://www.novartis.com/news/gt005-ppy988-development-program-geographic-atrophy",
    "timestamp": "unknown"
  },
  {
    "title": "StatementSep 01, 2023Novartis statement on filing of Inflation Reduction Act lawsuit",
    "link": "https://www.novartis.com/news/novartis-statement-filing-inflation-reduction-act-lawsuit",
    "timestamp": "unknown"
  },
  {
    "title": "StatementAug 29, 2023Novartis statement about Entresto\u00ae  (sacubitril/valsartan) selection for Medicare Drug Price Negotiation Program",
    "link": "https://www.novartis.com/news/novartis-statement-about-entresto-sacubitrilvalsartan-selection-medicare-drug-price-negotiation-program",
    "timestamp": "unknown"
  },
  {
    "title": "StatementAug 04, 2023European Commission (EC) adopts decision endorsing CHMP recommendation to revoke the conditional marketing authorization for Adak",
    "link": "https://www.novartis.com/news/european-commission-ec-adopts-decision-endorsing-chmp-recommendation-revoke-conditional-marketing-authorization-adakveo-crizanlizumab",
    "timestamp": "unknown"
  },
  {
    "title": "StatementMay 26, 2023CHMP recommends revoking the conditional marketing authorization for Adakveo\u00ae (crizanlizumab)",
    "link": "https://www.novartis.com/news/chmp-recommends-revoking-conditional-marketing-authorization-adakveo-crizanlizumab",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 22, 2025Access to HealthcareWhy advocating for your MS is so importantStoryApr 15, 2025People and CultureScience in Motion: Autumn and Sabrin",
    "link": "https://www.novartis.com/stories/why-advocating-your-ms-so-important",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 22, 2025Access to HealthcareWhy advocating for your MS is so importantStoryApr 15, 2025People and CultureScience in Motion: Autumn and Sabrin",
    "link": "https://www.novartis.com/stories/why-advocating-your-ms-so-important",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 22, 2025Access to HealthcareWhy advocating for your MS is so importantStoryApr 15, 2025People and CultureScience in Motion: Autumn and Sabrin",
    "link": "https://www.novartis.com/stories/why-advocating-your-ms-so-important",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 22, 2025Access to HealthcareWhy advocating for your MS is so importantStoryApr 15, 2025People and CultureScience in Motion: Autumn and Sabrin",
    "link": "https://www.novartis.com/stories/why-advocating-your-ms-so-important",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 22, 2025Access to HealthcareWhy advocating for your MS is so important",
    "link": "https://www.novartis.com/stories/why-advocating-your-ms-so-important",
    "timestamp": "unknown"
  },
  {
    "title": "StoryApr 15, 2025People and CultureScience in Motion: Autumn and Sabrina's Noteworthy Novartis AdventureIn the ever-evolving world of STEM, where inno",
    "link": "https://www.novartis.com/stories/science-motion-autumn-and-sabrinas-noteworthy-novartis-adventure",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMar 24, 2025Patient PerspectivesMarc\u2019s story: Raising awareness of elevated Lp(a) in cardiovascular disease",
    "link": "https://www.novartis.com/stories/marcs-story-raising-awareness-elevated-lpa-cardiovascular-disease",
    "timestamp": "unknown"
  },
  {
    "title": "StoryFeb 28, 2025People and CultureParental leave \u2013 A leadership opportunityAt Novartis, we believe in the importance of balancing professional and pe",
    "link": "https://www.novartis.com/stories/parental-leave-leadership-opportunity",
    "timestamp": "unknown"
  },
  {
    "title": "StoryNov 22, 2024People and CultureBiologist to Head-hunterI sometimes overlook what I\u2019ve achieved or overcome to arrive at this point in my career. T",
    "link": "https://www.novartis.com/stories/biologist-head-hunter",
    "timestamp": "unknown"
  },
  {
    "title": "StoryNov 21, 2024DiscoveryAddressing unmet needs for inherited neuromuscular diseasesNovartis has acquired Kate Therapeutics to further enhance and st",
    "link": "https://www.novartis.com/stories/addressing-unmet-needs-inherited-neuromuscular-diseases",
    "timestamp": "unknown"
  },
  {
    "title": "StoryOct 29, 2024People and CultureCareersMy journey to Novartis: Finding my purpose and passionWhen I first joined Novartis, I was nervous yet open t",
    "link": "https://www.novartis.com/stories/my-journey-novartis-finding-my-purpose-and-passion",
    "timestamp": "unknown"
  },
  {
    "title": "StoryAug 15, 2024Access to HealthcareNegative impact of the IRA on patient access to innovative treatmentsAt Novartis, we are constantly pushing the l",
    "link": "https://www.novartis.com/stories/negative-impact-ira-patient-access-innovative-treatments",
    "timestamp": "unknown"
  },
  {
    "title": "StoryAug 13, 2024People and CultureEvery number has a story \u2013 my journey to Novartis as a RefugeeThe current refugee crisis is one of the world's grea",
    "link": "https://www.novartis.com/stories/every-number-has-story-my-journey-novartis-refugee",
    "timestamp": "unknown"
  },
  {
    "title": "StoryAug 02, 2024People and CultureIs Diversity, Equity and Inclusion (DEI) really that important?We think so and here are just some of the reasons wh",
    "link": "https://www.novartis.com/stories/diversity-equity-and-inclusion-dei-really-important",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 31, 2024DiscoveryA legacy of blood cancer innovationBuilding on more than two decades of chronic myeloid leukemia research, the R&D teams at ",
    "link": "https://www.novartis.com/stories/legacy-blood-cancer-innovation",
    "timestamp": "unknown"
  },
  {
    "title": "StoryMay 27, 2024People and CultureA personal journey full circle, from curiosity about life on Earth to transformative therapies at NovartisFrom curi",
    "link": "https://www.novartis.com/stories/personal-journey-full-circle-from-curiosity-about-life-earth-transformative-therapies-novartis",
    "timestamp": "unknown"
  },
  {
    "title": "All news",
    "link": "https://www.novartis.com/news/newsroom",
    "timestamp": "unknown"
  },
  {
    "title": "All news",
    "link": "https://www.novartis.com/news/newsroom",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Financial Results \u2013 Q2 2025Novartis announces the company\u2019s financial results for the second quarter and first half of 2025.Learn more",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Financial Results \u2013 Q2 2025Novartis announces the company\u2019s financial results for the second quarter and first half of 2025.Learn more",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Financial Results \u2013 Q2 2025Novartis announces the company\u2019s financial results for the second quarter and first half of 2025.Learn more",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Financial Results \u2013 Q2 2025Novartis announces the company\u2019s financial results for the second quarter and first half of 2025.Learn more",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Learn more",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Learn more",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Learn more",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis in Society Integrated Report 2024The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and d",
    "link": "https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis in Society Integrated Report 2024The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and d",
    "link": "https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis in Society Integrated Report 2024The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and d",
    "link": "https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis in Society Integrated Report 2024The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and d",
    "link": "https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis in Society Integrated Report 2024The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and d",
    "link": "https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis in Society Integrated Report 2024The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and d",
    "link": "https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis in Society Integrated Report 2024The Novartis in Society Integrated Report provides an overview our business, strategy and performance, and d",
    "link": "https://www.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Live. MagazineLive is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Learn more",
    "link": "https://live.novartis.com/",
    "timestamp": "unknown"
  },
  {
    "title": "StoriesOur research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.EventsKeep in",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "StoriesOur research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.EventsKeep in",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "StoriesOur research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.EventsKeep in",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "StoriesOur research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.EventsKeep in",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "StoriesOur research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.EventsKeep in",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "StoriesOur research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.EventsKeep in",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "StoriesOur research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.EventsKeep in",
    "link": "https://www.novartis.com/stories",
    "timestamp": "unknown"
  },
  {
    "title": "Media contactsFind contacts at Novartis for media and journalist inquiries from the general and individual contacts.Media libraryBrowse and download m",
    "link": "https://www.novartis.com/contacts/media-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Media contactsFind contacts at Novartis for media and journalist inquiries from the general and individual contacts.Media libraryBrowse and download m",
    "link": "https://www.novartis.com/contacts/media-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Media contactsFind contacts at Novartis for media and journalist inquiries from the general and individual contacts.Media libraryBrowse and download m",
    "link": "https://www.novartis.com/contacts/media-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Media contactsFind contacts at Novartis for media and journalist inquiries from the general and individual contacts.Media libraryBrowse and download m",
    "link": "https://www.novartis.com/contacts/media-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Media contactsFind contacts at Novartis for media and journalist inquiries from the general and individual contacts.Media libraryBrowse and download m",
    "link": "https://www.novartis.com/contacts/media-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Media contactsFind contacts at Novartis for media and journalist inquiries from the general and individual contacts.Media libraryBrowse and download m",
    "link": "https://www.novartis.com/contacts/media-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Media contactsFind contacts at Novartis for media and journalist inquiries from the general and individual contacts.Media libraryBrowse and download m",
    "link": "https://www.novartis.com/contacts/media-contacts",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "#NovartisNewsTweets from the Media Relations teamFollow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "Follow @NovartisNews",
    "link": "https://twitter.com/NovartisNews",
    "timestamp": "unknown"
  },
  {
    "title": "Get the latest news and updates from Novartis directly to your inbox.Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Get the latest news and updates from Novartis directly to your inbox.Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Get the latest news and updates from Novartis directly to your inbox.Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Get the latest news and updates from Novartis directly to your inbox.Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Subscribe",
    "link": "https://www.novartis.com/news/stay-up-to-date",
    "timestamp": "unknown"
  },
  {
    "title": "Working togetherWorking togetherPatients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestorsTopicsTopicsQ2 2025AccessESGS",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Working togetherWorking togetherPatients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestorsTopicsTopicsQ2 2025AccessESGS",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Working togetherWorking togetherPatients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestorsTopicsTopicsQ2 2025AccessESGS",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Working togetherWorking togetherPatients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestors",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Working togetherWorking togetherPatients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestors",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Working togetherWorking togetherPatients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestors",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Patients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestors",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Patients and caregiversHealthcare professionalsResearchersJob seekersJournalistsInvestors",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Patients and caregivers",
    "link": "https://www.novartis.com/patients-and-caregivers",
    "timestamp": "unknown"
  },
  {
    "title": "Healthcare professionals",
    "link": "https://www.novartis.com/healthcare-professionals",
    "timestamp": "unknown"
  },
  {
    "title": "Researchers",
    "link": "https://www.novartis.com/research-and-development",
    "timestamp": "unknown"
  },
  {
    "title": "Job seekers",
    "link": "https://www.novartis.com/careers",
    "timestamp": "unknown"
  },
  {
    "title": "Journalists",
    "link": "https://www.novartis.com/news",
    "timestamp": "unknown"
  },
  {
    "title": "Investors",
    "link": "https://www.novartis.com/investors",
    "timestamp": "unknown"
  },
  {
    "title": "TopicsTopicsQ2 2025AccessESGSpeakUp",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "TopicsTopicsQ2 2025AccessESGSpeakUp",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "TopicsTopicsQ2 2025AccessESGSpeakUp",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Q2 2025AccessESGSpeakUp",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Q2 2025AccessESGSpeakUp",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Q2 2025",
    "link": "https://www.novartis.com/events/novartis-financial-results-q2-2025",
    "timestamp": "unknown"
  },
  {
    "title": "Access",
    "link": "https://www.novartis.com/esg/access",
    "timestamp": "unknown"
  },
  {
    "title": "ESG",
    "link": "https://www.novartis.com/esg",
    "timestamp": "unknown"
  },
  {
    "title": "SpeakUp",
    "link": "https://www.novartis.com/esg/ethics-risk-and-compliance/ethical-behavior/speakup",
    "timestamp": "unknown"
  },
  {
    "title": "ExploreExplorePipelineProductsClinical trialsPartneringEvents",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "ExploreExplorePipelineProductsClinical trialsPartneringEvents",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "ExploreExplorePipelineProductsClinical trialsPartneringEvents",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "PipelineProductsClinical trialsPartneringEvents",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "PipelineProductsClinical trialsPartneringEvents",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "Pipeline",
    "link": "https://www.novartis.com/research-development/novartis-pipeline",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://www.novartis.com/about/products",
    "timestamp": "unknown"
  },
  {
    "title": "Clinical trials",
    "link": "https://www.novartis.com/clinicaltrials",
    "timestamp": "unknown"
  },
  {
    "title": "Partnering",
    "link": "https://www.novartis.com/partnering",
    "timestamp": "unknown"
  },
  {
    "title": "Events",
    "link": "https://www.novartis.com/events",
    "timestamp": "unknown"
  },
  {
    "title": "Therapeutic areasTherapeutic areasCardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Therapeutic areasTherapeutic areasCardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Therapeutic areasTherapeutic areasCardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolicImmunologyNeuroscienceOncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Cardiovascular, renal and metabolic",
    "link": "https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic",
    "timestamp": "unknown"
  },
  {
    "title": "Immunology",
    "link": "https://www.novartis.com/about/therapeutic-areas/immunology",
    "timestamp": "unknown"
  },
  {
    "title": "Neuroscience",
    "link": "https://www.novartis.com/about/therapeutic-areas/neuroscience",
    "timestamp": "unknown"
  },
  {
    "title": "Oncology",
    "link": "https://www.novartis.com/about/therapeutic-areas/oncology",
    "timestamp": "unknown"
  },
  {
    "title": "Terms of use",
    "link": "https://www.novartis.com/terms-use",
    "timestamp": "unknown"
  },
  {
    "title": "Privacy",
    "link": "https://www.novartis.com/privacy",
    "timestamp": "unknown"
  },
  {
    "title": "Contacts",
    "link": "https://www.novartis.com/contacts",
    "timestamp": "unknown"
  },
  {
    "title": "Locations",
    "link": "https://www.novartis.com/about/locations",
    "timestamp": "unknown"
  },
  {
    "title": "Site map",
    "link": "https://www.novartis.com/sitemap.xml",
    "timestamp": "unknown"
  },
  {
    "title": "Open source",
    "link": "https://www.novartis.com/open-source",
    "timestamp": "unknown"
  },
  {
    "title": "Web accessibility",
    "link": "https://www.novartis.com/accessibility",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Site DirectoryThis site is intended for a global audience",
    "link": "https://www.novartis.com/novartis-directory",
    "timestamp": "unknown"
  },
  {
    "title": "Novartis Site Directory",
    "link": "https://www.novartis.com/novartis-directory",
    "timestamp": "unknown"
  }
]